- The stock price of Cellectis SA (NASDAQ: CLLS) fell by 23.01% in the most recent trading session. This is why.
The stock price of Cellectis SA (NASDAQ: CLLS) fell by 23.01% in the most recent trading session.
Why: Cellectis S.A. announced it is supplementing its previous announcement of the pricing of its underwritten global offering by way of a capital increase of 8.8 million American Depositary Shares (ADS), each representing the right to receive one ordinary share of Cellectis, nominal value €0.05 per share (the global offering), which launched and priced on February 2, 2023, at a price to the public of $2.50 per ADS as announced on February 2, 2023.
Timing: The closing of the Global Offering is expected to occur on or about February 7, 2023, subject to customary closing conditions.
Managers: Jefferies LLC and Barclays Capital Inc. are acting as joint book-running managers for the Global Offering.
